Navigating through the complexities of type 2 diabetes, a prevalent condition affecting millions worldwide, researchers are continuously exploring innovative avenues for managing and potentially mitigating its impact.
One such avenue being closely scrutinized is the role of testosterone replacement therapy (TRT) in men grappling with both diabetes and testosterone deficiency.
Linking Testosterone and Type 2 Diabetes
Almost two decades back, scientific circles buzzed with the revelation of a connection between low testosterone levels in men and the occurrence of type 2 diabetes.
Close to 40% of men dealing with type 2 diabetes were found to experience symptomatic testosterone deficiency, a condition that doesn’t merely stand isolated but is interwoven with adverse effects on cardiovascular health, bone density (osteoporosis), psychological wellness, and alarmingly, is associated with a twofold risk of death among men with type 2 diabetes.
Multiple studies have gradually unfolded the potential benefits of TRT for men suffering from testosterone deficiency (hypogonadism) and its positive implications on those dealing with type 2 diabetes, obesity, and other disorders related to metabolism and cardiovascular health.
Such benefits seemingly span reduced insulin resistance, better control of blood sugar levels (measured using HbA1c), diminished obesity, lowered mortality, and enhancements in quality of life and sexual function.
However, despite such promising results, the adoption of TRT in medical practice has been cautiously slow, partly attributed to conflicting reports regarding its cardiovascular risks, among other factors.
Delving into Real-World Data: The ABCD Audit
Presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Hamburg, preliminary data from an international audit, organized by the Association of British Clinical Diabetologists (ABCD), from 37 centers in eight countries showcased that TRT could potentially enhance glycemic control for up to two years.
The primary metric here, HbA1c, which signifies average blood sugar levels over approximately three months, showcased a downward trend, attributed to testosterone’s continued effect on insulin resistance and fat reduction.
This audit isn’t merely a collection of data but represents a beacon of hope and a potential answer to the long-standing controversial question: Can TRT positively impact diabetes and obesity?
ABCD Audit in Action: What the Preliminary Data Indicates
As per the early findings, after administering TRT, average HbA1c values showed a reduction across various intervals:
- After 3 months, it dropped from 71 mmol/mol to 66 mmol/mol.
- A more significant drop was observed after 12 months, moving from 71 mmol/mol to 61.7 mmol/mol.
- At the 24-month marker, it descended from 71.2 mmol/mol to 55 mmol/mol.
Professor Hugh Jones, who spearheaded the study, voiced the aspiration that the ABCD audit could serve as a comprehensive repository of real-world clinical data.
This data is crucial to discerning which patients positively respond to TRT in terms of symptom management, quality of life, and cardiometabolic benefits.
However, he emphasizes the need for “more and longer-term data from a larger number of patients” to deduce which patients are likely to respond positively to testosterone therapy.
Forward Stride: Informing Practice and Policy
These findings serve as a foundational layer to establish an evidence base for healthcare providers, particularly general practitioners and endocrinologists, to proactively inquire about symptoms with their patients with type 2 diabetes, and where indicated, diagnose and administer testosterone treatment aptly.
As this extensive audit continues to unravel more data, the medical community keenly observes, with the hope that these findings might weave into practice and policy, potentially illuminating a new pathway in managing and potentially transforming the lives of those navigating through the challenges of type 2 diabetes.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and what you need to know about avocado and type 2 diabetes.
For more information about diabetes, please see recent studies about how to eat to prevent type 2 diabetes, and 5 vitamins that may prevent complication in diabetes.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
